Prognosis
CDC Gives Final Go-Ahead for Pfizer’s Pediatric Covid Vaccine
- Shots cleared to begin with agency director’s recommendations
- Move opens a new phase in the U.S. immunization campaign
This article is for subscribers only.
Younger children across the U.S. are now eligible to receive Pfizer Inc.’s Covid-19 vaccine, after the head of the Centers for Disease Control and Prevention granted the final clearance needed for shots to begin.
CDC Director Rochelle Walensky recommended the vaccine for children from 5 to 11 years old. The decision ushers in a new phase in the U.S. pandemic response, widening access to vaccines to some 28 million more people at the same time that Americans who received shots earlier in the pandemic are lining up for booster doses.